Featured Research

from universities, journals, and other organizations

Gene test shows who could benefit from statins to reduce colon cancer risk

Date:
April 23, 2010
Source:
University of Michigan Health System
Summary:
A genetic test can help determine in which patients cholesterol-lowering statin drugs might have the most benefit in also reducing the risk of colorectal cancer, a new study finds.

Stephen Gruber, M.D., Ph.D., M.P.H., U-M Comprehensive Cancer Center.
Credit: Image courtesy of University of Michigan Health System

A genetic test can help determine in which patients cholesterol-lowering statin drugs might have the most benefit in also reducing the risk of colorectal cancer, a new study from researchers at the University of Michigan Comprehensive Cancer Center finds.

Related Articles


The researchers had previously shown that statins -- which 25 million people worldwide take each day to reduce their risk of cardiovascular disease -- can cut risk of colorectal cancer by 50 percent. But statins do not appear to work equally well for everyone in reducing either colorectal cancer or cardiovascular disease risk.

The new study, which appears in the May 1 issue of Cancer Prevention Research, found a genetic variant affects how statins control both colorectal cancer and cardiovascular disease risk.

"Our research is the first step towards personalized prevention. Some people benefit substantially more from statins than others -- for both cholesterol lowering and colorectal cancer prevention. Now we have identified a genetic test that can show who's likely to benefit most from this drug," says senior study author Stephen Gruber, M.D., Ph.D., M.P.H., director of cancer prevention and control at the U-M Comprehensive Cancer Center.

The study was led by Gruber, Steven M. Lipkin, M.D., Ph.D., from Weill Cornell Medical College; Gad Rennert, M.D., Ph.D., from Carmel Medical Center and the Technion-Israel Institute of Technology in Israel; and Levy Kopelovich, Ph.D., from the National Cancer Institute.

The team looked at 2,138 people in Northern Israel who were diagnosed with colon cancer and 2,049 similar people without colon cancer. All participants were asked about statin use for controlling cholesterol. Statins are not currently used to prevent colorectal cancer.

In addition, the researchers took blood samples from all study participants and analyzed the genes. They found that the gene targeted by statins, HMGCR, is the same gene that predicts the drug's benefit for preventing colorectal cancer. Further, there are two versions of HMGCR -- a long version and a short version. The researchers found that statins have more benefit for reducing both colorectal cancer risk and cholesterol in the gene's long version.

"It's the exact same mechanism for lowering cholesterol as it is for lowering colon cancer risk. This is true only for those people who are actually taking statins. The gene test by itself doesn't predict whether you're at an increased risk of colon cancer; it predicts only how well statins lower the risk," Gruber says.

The researchers point out that it's easy to know if statins are successfully lowering cholesterol, but their effect on colorectal cancer prevention is not as apparent. That's where a gene test would come in.

"We think we understand the reasons why statins lower the risk of colorectal cancer. It's probably related to the fact that in addition to lowering cholesterol, they also decrease inflammation -- and we know inflammation is a very important part of the way in which colon cancers develop. But regardless of whether it's related to cholesterol levels itself or inflammation, it's more important to know who are the right people to use these drugs for," says Gruber, H. Marvin Pollard Professor of Internal Medicine and professor of epidemiology and human genetics at the U-M Medical School and School of Public Health.

Note for patients: Statins are not currently approved by the U.S. Food and Drug Administration for colorectal cancer prevention. No gene test is available for determining statins' effectiveness. Talk to your health care provider for information about lowering your cancer risk.

Colorectal cancer statistics: 146,970 Americans will be diagnosed with colorectal cancer this year and 49,920 will die from the disease, according to the American Cancer Society

Additional authors: Liz Chao and Diana Dizon, from University of California, Irvine; Victor Moreno, from U-M and University of Barcelona; Laura S. Rozek, from U-M; Hedy Rennert and Mila Pinchev, from Clalit Health Services National Cancer Control Center, Carmel Medical Center, Technion-Israel Institute of Technology

Funding: National Cancer Institute grants; Spanish Secretaria de Estado de Universidades e Investigacion grant; Ravitz Foundation


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Steven M. Lipkin, Liz Chao, Victor Moreno, Laura S. Rozek, Hedy Rennert, Mila Pinchev, Diana Dizon, Gad Rennert, Levy Kopelovich, and Stephen B. Gruber. Genetic Variation in 3-Hydroxy-3-Methylglutaryl CoA Reductase Modifies the Chemopreventive Activity of Statins for Colorectal Cancer. Cancer Prevention Research, 2010; DOI: 10.1158/1940-6207.CAPR-10-0007

Cite This Page:

University of Michigan Health System. "Gene test shows who could benefit from statins to reduce colon cancer risk." ScienceDaily. ScienceDaily, 23 April 2010. <www.sciencedaily.com/releases/2010/04/100419162121.htm>.
University of Michigan Health System. (2010, April 23). Gene test shows who could benefit from statins to reduce colon cancer risk. ScienceDaily. Retrieved December 19, 2014 from www.sciencedaily.com/releases/2010/04/100419162121.htm
University of Michigan Health System. "Gene test shows who could benefit from statins to reduce colon cancer risk." ScienceDaily. www.sciencedaily.com/releases/2010/04/100419162121.htm (accessed December 19, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, December 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Kids Die While Under Protective Services

Kids Die While Under Protective Services

AP (Dec. 18, 2014) As part of a six-month investigation of child maltreatment deaths, the AP found that hundreds of deaths from horrific abuse and neglect could have been prevented. AP's Haven Daley reports. (Dec. 18) Video provided by AP
Powered by NewsLook.com
Dads-To-Be Also Experience Hormone Changes During Pregnancy

Dads-To-Be Also Experience Hormone Changes During Pregnancy

Newsy (Dec. 18, 2014) A study from University of Michigan researchers found that expectant fathers see a decrease in testosterone as the baby's birth draws near. Video provided by Newsy
Powered by NewsLook.com
Prenatal Exposure To Pollution Might Increase Autism Risk

Prenatal Exposure To Pollution Might Increase Autism Risk

Newsy (Dec. 18, 2014) Harvard researchers found children whose mothers were exposed to high pollution levels in the third trimester were twice as likely to develop autism. Video provided by Newsy
Powered by NewsLook.com
UN: Up to One Million Facing Hunger in Ebola-Hit Countries

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

AFP (Dec. 17, 2014) Border closures, quarantines and crop losses in West African nations battling the Ebola virus could lead to as many as one million people going hungry, UN food agencies said on Wednesday. Duration: 00:52 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins